---
title: "Sirtex Medical announces commercial availability of liquid embolic system"
date: "2023-11-03T16:44:09.000Z"
publishedDate: "3 novembre 2023"
summary: "Sirtex Medical, a leading manufacturer of interventional treatment solutions, has announced the commercial availability of the LAVA liquid embolic system, the first and only liquid embolic approved for the treatment of peripheral vascular haemorrhage. LAVA provides volume and viscosity options that optimise the flexibility needed to treat patients with controlled target vessel occlusion."
importance: ""
sourceUrl: "https://interventionalnews.com/sirtex-medical-announces-commercial-availability-of-liquid-embolic-system/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2023-11-03-sirtex-medical-announces-commercial-availability-of-liquid-embolic-system"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2022/02/Sirtex_Medical_Logo-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/sirtex-medical-announces-commercial-availability-of-liquid-embolic-system/"
---

![Sirtex Medical announces commercial availability of liquid embolic system](https://interventionalnews.com/wp-content/uploads/sites/13/2022/02/Sirtex_Medical_Logo-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/sirtex-medical-announces-commercial-availability-of-liquid-embolic-system/*

## L’essentiel

Sirtex Medical, a leading manufacturer of interventional treatment solutions, has announced the commercial availability of the LAVA liquid embolic system, the first and only liquid embolic approved for the treatment of peripheral vascular haemorrhage. LAVA provides volume and viscosity options that optimise the flexibility needed to treat patients with controlled target vessel occlusion.

## Lien source

https://interventionalnews.com/sirtex-medical-announces-commercial-availability-of-liquid-embolic-system/
